Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions

Expertise, Technology, and Infrastructure for Your Tuberculosis Testing Needs

TB Testing CapabilitiesThe theme for World Tuberculosis (TB) Day 2018 is “Wanted: Leaders for a TB-free world”. Q2 Solutions’ industry-leading scientists have over 35 years experience in infectious disease and immunology assay development and clinical trial testing.

Having a vaccine center of excellence in Pretoria, South Africa with dedicated TB testing capabilities, we proudly aim to make a contribution to a globally united effort to end TB.

Download our new infographic to learn more about how our specialized TB testing capabilities, expertise, and infrastructure can help advance your study.

Related Services: Related Blogs:
Q2 Solutions Anti-infective and Vaccine Development Services

Delivery Excellence for Anti-infective and Vaccine Development

Supply chain and quality management systems to ensure sample integrity for high-quality data delivery

Keeping Up with the Flu: Advances in seasonal influenza vaccine development

Assays to drive success in anti-infective and vaccine development

Extensive expertise for vaccine assay development and diagnostics

Harnessing innovative technologies for clinical trials involving emerging and re-emerging infectious diseases

Tools for better management of infectious disease clinical trials

Zika Vaccine Research: Complex Steps Toward a Critical Need

Overcoming Zika vaccine development challenges

Combating Emerging and Re-Emerging Infectious Diseases in Clinical Trials by Harnessing Innovative Technologies

Read More